You are here

New tool to assess costs and benefits of US cancer therapy

Los Angeles

AS options for cancer patients become increasingly complicated, and expensive, the most influential source for US oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies.

The National Comprehensive...

Market voices on: